PO Box 1488
Warrenville, IL 60555
Phone: 331.248.7888
Email: sidp@affinity-strategies.com
Dr. Fidelia Bernice, Dr. Rodrigo Burgos, and Dr. Neha Pandit, join Breakpoints to discuss the first available long-acting antiretroviral agent, cabotegravir/rilpivirine.
Rodrigo Burgos, PharmD, AAHIVP
Rodrigo Burgos is the director for the PGY2 ID pharmacy residency, PGY3 HIV residency, and assistant director for the PGY2 HIV residency at University of Illinois, Chicago. He is also a faculty member at the University of Illinois Retzky College of Pharmacy. He is panel member for the NIH-CDC-HIVMA/IDSA Pharmacology Group.
Neha Pandit, PharmD, BCPS, AAHIVP
Neha Pandit is a clinical pharmacy specialist in the HIV ambulatory care clinic and Oncology ID clinic at University of Maryland Medical System. She is also a Professor and Co-Vice Chair for Research and Scholarship in the Department of Practice, Sciences, and Health Outcomes Research in the University of Maryland School of Pharmacy.
